These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3176107)

  • 41. Development of a population pharmacokinetic model for carbamazepine based on sparse therapeutic monitoring data from pediatric patients with epilepsy.
    Carlsson KC; Hoem NO; Glauser T; Vinks AA
    Clin Ther; 2005 May; 27(5):618-26. PubMed ID: 15978311
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intravenous theophylline therapy: nomogram guidelines.
    Jusko WJ; Koup JR; Vance JW; Schentag JJ; Kuritzky P
    Ann Intern Med; 1977 Apr; 86(4):400-4. PubMed ID: 848801
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sustained-release terbutaline vs sustained-release theophylline in young patients with asthma.
    Roberts JR; Desai HI; Gillespie CA; Simons FE
    Am J Dis Child; 1986 Jul; 140(7):650-4. PubMed ID: 3717101
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predictive performance of a vancomycin-aminoglycoside population model.
    Beringer PM; Wong-Beringer A; Rho JP
    Ann Pharmacother; 1998 Feb; 32(2):176-81. PubMed ID: 9496400
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of three theophylline dosing equations for use in infants up to one year of age.
    Hogue SL; Phelps SJ
    J Pediatr; 1993 Oct; 123(4):651-6. PubMed ID: 8192745
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Methods for Predicting Warfarin Dose Requirements.
    Saffian SM; Wright DF; Roberts RL; Duffull SB
    Ther Drug Monit; 2015 Aug; 37(4):531-8. PubMed ID: 25549208
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Absorption kinetics and steady-state plasma concentrations of theophylline following therapeutic doses of two sustained-release preparations.
    Andersen O; Nielsen MK; Eriksen PB; Fenger M; Knudsen PJ
    J Pharm Sci; 1983 Feb; 72(2):158-61. PubMed ID: 6834254
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative bioavailability of two sustained-release theophylline formulations in the dog.
    Mengozzi G; Intorre L; Bertini S; Giorgi M; Soldani G
    Pharmacol Res; 1998 Dec; 38(6):481-5. PubMed ID: 9990658
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetic comparison of a once-daily and twice-daily theophylline delivery system.
    González MA; Kisicki J; Straughn AB
    Clin Ther; 1994; 16(4):686-92. PubMed ID: 7982257
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of trovafloxacin, a new fluoroquinolone antibiotic, on the steady-state pharmacokinetics of theophylline in healthy volunteers.
    Vincent J; Teng R; Dogolo LC; Willavize SA; Friedman HL
    J Antimicrob Chemother; 1997 Jun; 39 Suppl B():81-6. PubMed ID: 9222075
    [TBL] [Abstract][Full Text] [Related]  

  • 51. NTP Toxicology and Carcinogenesis Studies of Theophylline (CAS No. 58-55-9) in F344/N Rats and B6C3F1 Mice (Feed and Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1998 Aug; 473():1-326. PubMed ID: 12571677
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The usefulness of the bayesian method for the prediction of plasma theophylline levels in asthmatic children during RTC therapy by the sustained preparation of theophylline].
    Okabe T; Hida M; Maruyama K; Kohgo T; Shibuya M; Ohashi A
    Arerugi; 1994 Apr; 43(4):563-70. PubMed ID: 8031252
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A multiple-dose study of sustained-release theophylline and aminophylline.
    Meyer MC; Straughn AB; Lieberman P
    Chest; 1980 Aug; 78(2):300-3. PubMed ID: 7398417
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Theophylline dose prediction.
    Beswick DT; Cullen RE; Rylance GW
    Arch Dis Child; 1984 Aug; 59(8):758-61. PubMed ID: 6476875
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Individualization of theophylline dosage using a single serum sample following a test dose.
    Shapiro GG; Koup JR; Furukawa CT; Pierson WE; Gibaldi M; Fuquay D; Bierman CW
    Pediatrics; 1982 Jan; 69(1):70-3. PubMed ID: 7054763
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum theophylline concentrations during multiple dosing with two sustained release methylxanthine preparations in normal subjects.
    Prior JG; Berry D; Cochrane GM
    Postgrad Med J; 1980 Sep; 56(659):638-41. PubMed ID: 7465472
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An updated comparison of drug dosing methods. Part II: Theophylline.
    Erdman SM; Rodvold KA; Pryka RD
    Clin Pharmacokinet; 1991 Apr; 20(4):280-92. PubMed ID: 1903683
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of aminophylline and theophylline sustained-release formulations by their bioavailability and steady-state serum levels.
    Steinijans VW; Zech K; Fischer R
    Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):624-30. PubMed ID: 6668100
    [TBL] [Abstract][Full Text] [Related]  

  • 59. No influence of doxycycline on theophylline pharmacokinetics.
    Jonkman JH; van der Boon WJ; Schoenmaker R; Holtkamp A; Hempenius J
    Ther Drug Monit; 1985; 7(1):92-4. PubMed ID: 3992627
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Analytical goals for determinations of theophylline concentration in serum.
    Jenny RW
    Clin Chem; 1991 Feb; 37(2):154-8. PubMed ID: 1993318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.